SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-007134
Filing Date
2018-05-15
Accepted
2018-05-15 16:54:56
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 317607
2 ex-31.htm EX-31 33443
3 ex-32.htm EX-32 8473
  Complete submission text file 0001493152-18-007134.txt   2318021

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ocx-20180331.xml EX-101.INS 298645
5 XBRL SCHEMA FILE ocx-20180331.xsd EX-101.SCH 30489
6 XBRL CALCULATION FILE ocx-20180331_cal.xml EX-101.CAL 46003
7 XBRL DEFINITION FILE ocx-20180331_def.xml EX-101.DEF 110781
8 XBRL LABEL FILE ocx-20180331_lab.xml EX-101.LAB 242692
9 XBRL PRESENTATION FILE ocx-20180331_pre.xml EX-101.PRE 187506
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 18837458
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1